Rankings
▼
Calendar
FHTX (Foghorn Therapeutics Inc.) Stock Financials & Earnings | Market Cap Arena
FHTX
Foghorn Therapeutics Inc.
Mkt Cap
$330M
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$25M
Net Income (TTM)
-$72M
EPS (TTM)
-$1.14
Free Cash Flow (TTM)
-$89M
Gross Margin
14.7%
Op. Margin
-352.9%
Net Margin
-294.2%
FCF Margin
-362.5%
P/S Ratio (TTM)
13.5x
P/E Ratio (TTM)
—
YoY Rev Growth
-3.9%
Employees
—
Earnings Reports
▶
Q3 2025
Browse All Reports
Next: Q4 2025 · Mar 12
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q4 22
$4M
-$24M
-$32M
Q1 23
$5M
$5M
-$33M
Q2 23
$6M
-$24M
-$32M
Q3 23
$17M
-$9M
-$17M
Q4 23
$6M
$5M
-$25M
Q1 24
$5M
$5M
-$28M
Q2 24
$7M
$7M
-$27M
Q3 24
$8M
$8M
-$24M
Q4 24
$3M
$3M
-$24M
Q1 25
$6M
$6M
-$23M
Q2 25
$8M
$7M
-$21M
Q3 25
$8M
-$12M
-$19M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q4 22
17.2x
—
Q1 23
16.0x
—
Q2 23
15.2x
—
Q3 23
10.1x
—
Q4 23
9.7x
—
Q1 24
9.7x
—
Q2 24
9.4x
—
Q3 24
12.9x
—
Q4 24
14.6x
—
Q1 25
14.1x
—
Q2 25
13.7x
—
Q3 25
13.5x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q4 22
-$29M
-$29M
Q1 23
-$31M
-$32M
Q2 23
-$32M
-$33M
Q3 23
-$27M
-$27M
Q4 23
-$28M
-$28M
Q1 24
-$29M
-$29M
Q2 24
-$26M
-$26M
Q3 24
-$21M
-$21M
Q4 24
-$25M
-$25M
Q1 25
-$24M
-$24M
Q2 25
-$21M
-$21M
Q3 25
-$19M
-$19M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q4 22
$269K
Q1 23
$636K
Q2 23
$469K
Q3 23
$82K
Q4 23
$37K
Q1 24
$101K
Q2 24
$17K
Q3 24
$309K
Q4 24
$479K
Q1 25
$28K
Q2 25
$22K
Q3 25
$0
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q4 22
+486.8%
+25.3%
Q1 23
+35.4%
+21.8%
Q2 23
+24.7%
+11.8%
Q3 23
+163.5%
-1.0%
Q4 23
+37.9%
-13.4%
Q1 24
-4.9%
-13.9%
Q2 24
+23.0%
-11.0%
Q3 24
-55.3%
-8.4%
Q4 24
-50.5%
-14.0%
Q1 25
+17.9%
-13.2%
Q2 25
+9.7%
-14.5%
Q3 25
+4.4%
-15.8%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q4 22
$0
0.0%
Q1 23
$5M
86.1%
Q2 23
$0
0.0%
Q3 23
$4M
23.4%
Q4 23
$3M
52.9%
Q1 24
$3M
63.8%
Q2 24
$0
0.0%
Q3 24
$0
0.0%
Q4 24
$2M
86.9%
Q1 25
$3M
45.2%
Q2 25
$3M
36.2%
Q3 25
$0
0.0%
marketcaparena.com
OpEx Breakdown
R&D
G&A
Quarter
R&D
G&A
Q4 22
$28M
$8M
Q1 23
$30M
$9M
Q2 23
$29M
$8M
Q3 23
$26M
$8M
Q4 23
$23M
$7M
Q1 24
$26M
$8M
Q2 24
$24M
$7M
Q3 24
$25M
$7M
Q4 24
$21M
$6M
Q1 25
$22M
$7M
Q2 25
$21M
$7M
Q3 25
$20M
$7M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q4 22
$52M
$294M
$346M
Q1 23
$51M
$265M
$316M
Q2 23
$58M
$227M
$284M
Q3 23
$70M
$190M
$260M
Q4 23
$80M
$154M
$234M
Q1 24
$79M
$127M
$207M
Q2 24
$139M
$146M
$285M
Q3 24
$58M
$210M
$267M
Q4 24
$55M
$188M
$244M
Q1 25
$61M
$160M
$221M
Q2 25
$73M
$126M
$199M
Q3 25
$89M
$91M
$180M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q4 22
42M
+0.3%
Q1 23
42M
+0.0%
Q2 23
42M
+0.0%
Q3 23
42M
+0.5%
Q4 23
42M
+0.6%
Q1 24
42M
+0.3%
Q2 24
52M
+21.6%
Q3 24
63M
+21.4%
Q4 24
63M
+0.0%
Q1 25
63M
+0.4%
Q2 25
63M
+0.2%
Q3 25
63M
+0.1%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 18
—
—
FY 19
—
—
FY 20
$5K
95
FY 21
$11K
119
FY 22
$119K
161
FY 23
$294K
116
FY 24
$202K
112
marketcaparena.com